RALLYBIO CORPORATION (RLYB) Net Margin
- 2026-03-31: Net Margin -3904.72%.
- 2025-12-31: Net Margin -2636.04%.
- 2025-09-30: Net Margin 7554.72%.
- 2025-06-30: Net Margin -4576.89%.
Complete source-backed net margin history.
- Available history
- 2024-06-30 to 2026-03-31
- Data captured
Historical Net Margin
| Date | Net Margin |
|---|---|
| 2026-03-31 | -3904.72% |
| 2025-12-31 | -2636.04% |
| 2025-09-30 | 7554.72% |
| 2025-06-30 | -4576.89% |
| 2025-03-31 | -4452.36% |
| 2024-12-31 | -29063.16% |
| 2024-09-30 | -3834.78% |
| 2024-06-30 | -5430.10% |
Annual Net Margin
| Date | Net Margin |
|---|---|
| 2025-12-31 | -1046.39% |
| 2024-12-31 | -9084.12% |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Acrivon Therapeutics, Inc. (ACRV) | United States | $0.091B | -1.03 |
| ONCOLYTICS BIOTECH INC (ONCY) | $0.086B | ||
| NEONC TECHNOLOGIES HOLDINGS, INC. (NTHI) | United States | $0.086B | |
| Lexaria Bioscience Corp. (LEXX) | $0.084B | -1.92 | |
| Telomir Pharmaceuticals, Inc. (TELO) | United States | $0.084B | |
| Anixa Biosciences Inc (ANIX) | United States | $0.096B | |
| CITIUS ONCOLOGY, INC. (CTOR) | United States | $0.097B | -1.49 |
| Gain Therapeutics, Inc. (GANX) | United States | $0.080B | -4.40 |
| Milestone Pharmaceuticals Inc. (MIST) | $0.098B | -2.00 | |
| Lifevantage Corp (LFVN) | United States | $0.078B | 15.40 |